Rockefeller Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.8M | Buy |
146,356
+9,407
| +7% | +$1.62M | 0.04% | 377 |
|
|
2026
Q1 | $23.1M | Sell |
136,949
-10,758
| -7% | -$1.84M | 0.04% | 404 |
|
|
2025
Q4 | $24.9M | Buy |
147,707
+21,052
| +17% | +$3.42M | 0.04% | 386 |
|
|
2025
Q3 | $18.3M | Sell |
126,655
-4,880
| -4% | -$666K | 0.04% | 439 |
|
|
2025
Q2 | $16.6M | Sell |
131,535
-11,796
| -8% | -$1.45M | 0.04% | 442 |
|
|
2025
Q1 | $18.3M | Buy |
143,331
+1,480
| +1% | +$201K | 0.05% | 389 |
|
|
2024
Q4 | $18.8M | Sell |
141,851
-4,943
| -3% | -$695K | 0.05% | 362 |
|
|
2024
Q3 | $21.4M | Sell |
146,794
-8,860
| -6% | -$1.28M | 0.06% | 317 |
|
|
2024
Q2 | $21.4M | Buy |
155,654
+36,491
| +31% | +$4.87M | 0.06% | 298 |
|
|
2024
Q1 | $16.4M | Buy |
119,163
+5,800
| +5% | +$792K | 0.05% | 377 |
|
|
2023
Q4 | $15.4M | Sell |
113,363
-463
| -0.4% | -$56.5K | 0.05% | 352 |
|
|
2023
Q3 | $13.9M | Buy |
113,826
+2,470
| +2% | +$314K | 0.05% | 344 |
|
|
2023
Q2 | $14.1M | Sell |
111,356
-95,403
| -46% | -$12.4M | 0.05% | 355 |
|
|
2023
Q1 | $26.7M | Buy |
206,759
+109,917
| +114% | +$14.4M | 0.11% | 202 |
|
|
2022
Q4 | $12.7M | Buy |
96,842
+13,574
| +16% | +$1.75M | 0.06% | 319 |
|
|
2022
Q3 | $9.74M | Sell |
83,268
-6,363
| -7% | -$790K | 0.05% | 363 |
|
|
2022
Q2 | $10.5M | Sell |
89,631
-3,702
| -4% | -$439K | 0.06% | 332 |
|
|
2022
Q1 | $12.2M | Sell |
93,333
-39,201
| -30% | -$5.11M | 0.06% | 321 |
|
|
2021
Q4 | $20.2M | Buy |
132,534
+25,454
| +24% | +$3.94M | 0.09% | 220 |
|
|
2021
Q3 | $17.3M | Buy |
107,080
+4,484
| +4% | +$755K | 0.09% | 231 |
|
|
2021
Q2 | $16.8M | Buy |
102,596
+23,548
| +30% | +$3.63M | 0.09% | 232 |
|
|
2021
Q1 | $11.9M | Buy |
79,048
+3,397
| +4% | +$540K | 0.08% | 238 |
|
|
2020
Q4 | $11.5M | Buy |
75,651
+23,888
| +46% | +$3.41M | 0.09% | 215 |
|
|
2020
Q3 | $7.01M | Buy |
51,763
+14,119
| +38% | +$1.92M | 0.07% | 230 |
|
|
2020
Q2 | $5.15M | Buy |
37,644
+13,428
| +55% | +$1.71M | 0.05% | 241 |
|
|
2020
Q1 | $2.61M | Buy |
24,216
+2,994
| +14% | +$345K | 0.03% | 301 |
|
|
2019
Q4 | $2.56M | Buy |
21,222
+6,768
| +47% | +$755K | 0.03% | 304 |
|
|
2019
Q3 | $1.44M | Buy |
14,454
+3,317
| +30% | +$347K | 0.02% | 336 |
|
|
2019
Q2 | $1.22M | Sell |
11,137
-1,472
| -12% | -$157K | 0.02% | 320 |
|
|
2019
Q1 | $1.41M | Buy |
12,609
+11,646
| +1,209% | +$1.28M | 0.02% | 319 |
|
|
2018
Q4 | $93K | Buy |
+963
| New | +$102K | ﹤0.01% | 462 |
|
|
2018
Q2 | – | Sell |
-7,500
| Closed | -$801K | – | 778 |
|
|
2018
Q1 | $801K | Buy |
+7,500
| New | +$831K | 0.01% | 235 |
|
Other funds holding IBB
CB
Rockefeller Capital Management's IBB Position: Q2 2026 in Review
Rockefeller Capital Management increased its iShares Biotechnology ETF (IBB) stake by 6.9% in Q2 2026, buying an estimated $1.62M and bringing the position to 146,356 shares worth $27.8M. The position accounts for 0.04% of the portfolio, ranked #377.
Rockefeller Capital Management first reported a position in IBB in Q1 2018 and has held it in 32 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Rockefeller Capital Management held 146,356 shares of iShares Biotechnology ETF worth $27.8M as of Q2 2026.
- Rockefeller Capital Management bought 9,407 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.62M.
- iShares Biotechnology ETF made up 0.04% of Rockefeller Capital Management's portfolio in Q2 2026, its #377 holding.
- Rockefeller Capital Management first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 32 quarters since.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.